Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-03-14 Sale |
2024-03-18 6:00 pm |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
48,871 | $5.39 | $263,415 | 732,919 (Direct) |
View |
2023-11-30 Sale |
2023-12-01 7:42 pm |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
965 | $1.97 | $1,901 | 381,790 (Direct) |
View |
2023-09-27 Sale |
2023-09-29 8:02 pm |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
9,720 | $2.7 | $26,244 | 382,755 (Direct) |
View |
2023-01-11 Sale |
2023-01-13 4:30 pm |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
4,495 | $0.91 | $4,090 | 392,475 (Direct) |
View |
2021-05-26 Sale |
2021-05-28 7:12 pm |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
2,894 | $18.35 | $53,105 | 33,570 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-12-21 Option Award |
2023-12-22 8:01 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
400,000 | $0 | 781,790 (Direct) |
View |
2023-01-11 Option Award |
2023-01-13 4:30 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
300,000 | $0 | 392,475 (Direct) |
View |
2022-04-13 Option Award |
2022-04-15 7:07 pm |
N/A 2032-04-13 |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
2022-01-07 Option Award |
2022-01-11 6:44 pm |
N/A 2032-01-07 |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
52,800 | $0 | 118,070 (Direct) |
View |
2021-12-14 Option Award(A) |
2022-01-11 6:41 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
31,700 | $0 | 65,270 (Direct) |
View |
2021-12-14 Option Award |
2021-12-16 8:29 pm |
N/A 2031-12-14 |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
52,800 | $0 | 86,370 (Direct) |
View |
2020-12-10 Option Award |
2020-12-14 9:42 pm |
N/A 2030-12-10 |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
81,700 | $0 | 81,700 (Direct) |
View |